Results 251 to 260 of about 1,318,851 (362)
Acupuncture as adjunctive therapy for acute cerebral infarction: a randomized clinical trial. [PDF]
Cao JP+14 more
europepmc +1 more source
After ischemic stroke, TRPV4 activation induces cerebral edema through the TRPV4‐RhoA‐MMP9 axis: RhoA upregulates MMP9, which cleaves β‐DG to impair membrane anchoring. Subsequent β‐DG loss triggers AQP4 depolarization, disrupting GS‐mediated water homeostasis.
Yongchuan Li+13 more
wiley +1 more source
Anatomical characteristics of the styloid process in cerebral infarction related to carotid artery dissection: a case-control study. [PDF]
Shi S, Wang L, Luo H, Fu Z, Liu Y.
europepmc +1 more source
1 H-NMR-Based Metabolomics Study of Cerebral Infarction
Jeeyoun Jung+7 more
semanticscholar +1 more source
Contribution of α‐synuclein cytopathologies to distinct seeding of misfolded α‐synuclein
This study investigated whether brain regions with distinct predominance of α‐synuclein (αSyn) cytopathologies show different αSyn seeding patterns in multiple system atrophy (MSA) and Lewy body disease (LBD), using an interdisciplinary approach. High seeding activity is observed in regions with oligodendrocytic‐predominant αSyn pathology in MSA.
Ain Kim+4 more
wiley +1 more source
Evolving of treatment options for cerebral infarction. [PDF]
Cao QY, Li Z.
europepmc +1 more source
A study of cerebral infarction of the basal ganglia due to main trunk obstruction
Toshihiko Iwamoto+3 more
openalex +2 more sources
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source